RaySearch Laboratories AB/Skr RAY B
08:00
10:05
12:15
14:20
16:25
1D1W1MYTD1Y5YMAX
About RaySearch Laboratories AB
RaySearch Laboratories AB is a medical technology company based in Sweden that specializes in software solutions for radiation therapy used in cancer treatment. The company's primary product is RayStation, an advanced treatment planning system that integrates a comprehensive set of tools for creating radiation therapy plans. Founded in 2000, RaySearch focuses heavily on research and development to innovate in adaptive therapy, automated planning, and machine learning. Its strategic partnerships with major equipment vendors expand its geographic presence, serving clinics and hospitals worldwide. The company's competitive strength lies in its advanced algorithms and focus on improving patient outcomes and treatment workflows.
Ticker
Skr RAY B
Sector
Primary listing
XSTO
Employees
458
Headquarters
Stockholm, Sweden
Website
RAY B Metrics
BasicAdvanced
kr 6.5B
28.57
kr 6.65
1.07
kr 3.00
1.58%
Price and volume
Market cap
kr 6.5B
Beta
1.07
52-week high
kr 373.50
52-week low
kr 166.80
Average daily volume
234K
Dividend rate
kr 3.00
Financial strength
Current ratio
1.703
Quick ratio
1.665
Long term debt to equity
32.203
Total debt to equity
40.069
Dividend payout ratio (TTM)
45.13%
Interest coverage (TTM)
64.98%
Profitability
EBITDA (TTM)
397.2
Gross margin (TTM)
92.42%
Net profit margin (TTM)
16.95%
Operating margin (TTM)
21.75%
Effective tax rate (TTM)
20.85%
Revenue per employee (TTM)
kr 2,940,000
Management effectiveness
Return on assets (TTM)
8.95%
Return on equity (TTM)
24.47%
Valuation
Price to earnings (TTM)
28.571
Price to revenue (TTM)
4.842
Price to book
6.63
Price to tangible book (TTM)
15.32
Price to free cash flow (TTM)
40.96
Free cash flow yield (TTM)
2.44%
Free cash flow per share (TTM)
4.639
Dividend yield (TTM)
1.58%
Forward dividend yield
1.58%
Growth
Revenue change (TTM)
12.77%
Earnings per share change (TTM)
12.02%
3-year revenue growth (CAGR)
16.80%
10-year revenue growth (CAGR)
12.95%
3-year earnings per share growth (CAGR)
112.81%
10-year earnings per share growth (CAGR)
12.50%
10-year dividend per share growth (CAGR)
31.95%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for RaySearch Laboratories AB stock?
RaySearch Laboratories AB (RAY B) has a market cap of Skr6.5B as of March 17, 2026.
What is the P/E ratio for RaySearch Laboratories AB stock?
The price to earnings (P/E) ratio for RaySearch Laboratories AB (RAY B) stock is 28.57 as of March 17, 2026.
Does RaySearch Laboratories AB stock pay dividends?
Yes, the RaySearch Laboratories AB (RAY B) stock pays dividends to shareholders. As of March 17, 2026, the dividend rate is Skr3 and the yield is 1.58%. RaySearch Laboratories AB has a payout ratio of 45.13% on a trailing twelve-month basis.
When is the next RaySearch Laboratories AB dividend payment date?
The next RaySearch Laboratories AB (RAY B) dividend payment is scheduled for May 15, 2026.
What is the beta indicator for RaySearch Laboratories AB?
RaySearch Laboratories AB (RAY B) has a beta rating of 1.07. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.